| Hampshire Center | |
| 260 Sunrise Boulevard, Romney, West Virginia 26757 | |
| (304) 822-7527 | |
| Name | Hampshire Center |
|---|---|
| Location | 260 Sunrise Boulevard, Romney, West Virginia |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 62 |
| Occupancy Rate | 85% |
| Medicare ID (CCN) | 515176 |
| Legal Business Name | Romney Health Care Center Ltd Ptr |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1124301643 |
| Address | Hc 63 Box 2580, Romney, WV 26757 |
| Phone Number | 304-822-7527 |
News Archive
Health officials are warning that the practice of chroming – inhaling solvents or other household chemicals – can have irreversible impacts on vital organs, including the brain.
EffRx Pharmaceuticals SA and its partner, the global pharmaceutical company Nycomed, headquartered in Zurich, Switzerland, today announced that the first European filing for marketing approval of EX101, a once-a-week 70mg buffered effervescent alendronate, for the treatment of osteoporosis, has been submitted. The filing triggers a milestone payment to EffRx.
Binghamton University researcher Ron Miles invented a tiny directional microphone - suitable for use in hearing aids - that filters out unwanted sounds. Now, with help from the SUNY Technology Accelerator Fund, he hopes to bring the idea to the marketplace.
DSM, and Svelte® Medical Systems, Inc., a privately held company developing next generation endovascular therapies, today announced they have entered into a license and supply agreement granting Svelte the right to use DSM's proprietary bioerodible amino acid based drug carrier in the design of their All In One non-thrombogenic, non-inflammatory drug-eluting stent system.
› Verified 8 days ago
| NPI Number | 1427084110 |
| Organization Name | ROMNEY HEALTH CARE CENTER LTD PTR |
| Doing Business As | HAMPSHIRE CENTER |
| Address | Hc 63, Romney, WV 26757 |
| Phone Number | 304-822-7527 |
News Archive
Health officials are warning that the practice of chroming – inhaling solvents or other household chemicals – can have irreversible impacts on vital organs, including the brain.
EffRx Pharmaceuticals SA and its partner, the global pharmaceutical company Nycomed, headquartered in Zurich, Switzerland, today announced that the first European filing for marketing approval of EX101, a once-a-week 70mg buffered effervescent alendronate, for the treatment of osteoporosis, has been submitted. The filing triggers a milestone payment to EffRx.
Binghamton University researcher Ron Miles invented a tiny directional microphone - suitable for use in hearing aids - that filters out unwanted sounds. Now, with help from the SUNY Technology Accelerator Fund, he hopes to bring the idea to the marketplace.
DSM, and Svelte® Medical Systems, Inc., a privately held company developing next generation endovascular therapies, today announced they have entered into a license and supply agreement granting Svelte the right to use DSM's proprietary bioerodible amino acid based drug carrier in the design of their All In One non-thrombogenic, non-inflammatory drug-eluting stent system.
› Verified 8 days ago
| NPI Number | 1609044692 |
| Organization Name | HC 63 OPERATIONS LLC |
| Doing Business As | HAMPSHIRE CENTER |
| Address | Hc 63, Romney, WV 26757 |
| Phone Number | 304-822-7527 |
News Archive
Health officials are warning that the practice of chroming – inhaling solvents or other household chemicals – can have irreversible impacts on vital organs, including the brain.
EffRx Pharmaceuticals SA and its partner, the global pharmaceutical company Nycomed, headquartered in Zurich, Switzerland, today announced that the first European filing for marketing approval of EX101, a once-a-week 70mg buffered effervescent alendronate, for the treatment of osteoporosis, has been submitted. The filing triggers a milestone payment to EffRx.
Binghamton University researcher Ron Miles invented a tiny directional microphone - suitable for use in hearing aids - that filters out unwanted sounds. Now, with help from the SUNY Technology Accelerator Fund, he hopes to bring the idea to the marketplace.
DSM, and Svelte® Medical Systems, Inc., a privately held company developing next generation endovascular therapies, today announced they have entered into a license and supply agreement granting Svelte the right to use DSM's proprietary bioerodible amino acid based drug carrier in the design of their All In One non-thrombogenic, non-inflammatory drug-eluting stent system.
› Verified 8 days ago
| NPI Number | 1821319039 |
| Organization Name | HAMPSHIRE CENTER |
| Address | Hc 63 Box 2580, Romney, WV 26757 |
| Phone Number | 304-822-7527 |
News Archive
Health officials are warning that the practice of chroming – inhaling solvents or other household chemicals – can have irreversible impacts on vital organs, including the brain.
EffRx Pharmaceuticals SA and its partner, the global pharmaceutical company Nycomed, headquartered in Zurich, Switzerland, today announced that the first European filing for marketing approval of EX101, a once-a-week 70mg buffered effervescent alendronate, for the treatment of osteoporosis, has been submitted. The filing triggers a milestone payment to EffRx.
Binghamton University researcher Ron Miles invented a tiny directional microphone - suitable for use in hearing aids - that filters out unwanted sounds. Now, with help from the SUNY Technology Accelerator Fund, he hopes to bring the idea to the marketplace.
DSM, and Svelte® Medical Systems, Inc., a privately held company developing next generation endovascular therapies, today announced they have entered into a license and supply agreement granting Svelte the right to use DSM's proprietary bioerodible amino acid based drug carrier in the design of their All In One non-thrombogenic, non-inflammatory drug-eluting stent system.
› Verified 8 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Health officials are warning that the practice of chroming – inhaling solvents or other household chemicals – can have irreversible impacts on vital organs, including the brain.
EffRx Pharmaceuticals SA and its partner, the global pharmaceutical company Nycomed, headquartered in Zurich, Switzerland, today announced that the first European filing for marketing approval of EX101, a once-a-week 70mg buffered effervescent alendronate, for the treatment of osteoporosis, has been submitted. The filing triggers a milestone payment to EffRx.
Binghamton University researcher Ron Miles invented a tiny directional microphone - suitable for use in hearing aids - that filters out unwanted sounds. Now, with help from the SUNY Technology Accelerator Fund, he hopes to bring the idea to the marketplace.
DSM, and Svelte® Medical Systems, Inc., a privately held company developing next generation endovascular therapies, today announced they have entered into a license and supply agreement granting Svelte the right to use DSM's proprietary bioerodible amino acid based drug carrier in the design of their All In One non-thrombogenic, non-inflammatory drug-eluting stent system.
› Verified 8 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 21.64 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 8.84 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 59.02 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.22 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 1.22 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 6.18 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 4.93 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 99.51 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 16.92 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 98.73 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 30.74 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 28.49 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 2.9 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 99.56 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 69.31 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 93.65 | 82.93 |
News Archive
Health officials are warning that the practice of chroming – inhaling solvents or other household chemicals – can have irreversible impacts on vital organs, including the brain.
EffRx Pharmaceuticals SA and its partner, the global pharmaceutical company Nycomed, headquartered in Zurich, Switzerland, today announced that the first European filing for marketing approval of EX101, a once-a-week 70mg buffered effervescent alendronate, for the treatment of osteoporosis, has been submitted. The filing triggers a milestone payment to EffRx.
Binghamton University researcher Ron Miles invented a tiny directional microphone - suitable for use in hearing aids - that filters out unwanted sounds. Now, with help from the SUNY Technology Accelerator Fund, he hopes to bring the idea to the marketplace.
DSM, and Svelte® Medical Systems, Inc., a privately held company developing next generation endovascular therapies, today announced they have entered into a license and supply agreement granting Svelte the right to use DSM's proprietary bioerodible amino acid based drug carrier in the design of their All In One non-thrombogenic, non-inflammatory drug-eluting stent system.
› Verified 8 days ago
Hampshire Memorial Hospital Location: 363 Sunrise Blvd, Romney, West Virginia 26757 Phone: (304) 822-4561 | |